Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 19,965 | 22,668 | 25,400 | 35,083 | 42,624 |
| Cost of Goods | 7,170 | 9,005 | 10,622 | 15,874 | 17,195 |
| Gross Profit | 12,795 | 13,663 | 14,778 | 19,209 | 25,429 |
| Operating Expenses | 71,349 | 69,417 | 68,134 | 79,445 | 60,477 |
| Operating Income | -58,384 | -55,749 | -52,734 | -59,362 | -34,853 |
| Other Income | 156 | 559 | 1,155 | 1,442 | 1,258 |
| Pre-tax Income | -58,228 | -55,190 | -51,579 | -57,920 | -33,595 |
| Net Income Continuous | -58,228 | -55,190 | -51,579 | -57,920 | -33,595 |
| Net Income | $-58,228 | $-55,190 | $-51,579 | $-57,920 | $-33,595 |
| EPS Basic Total Ops | -0.64 | -0.61 | -0.57 | -0.65 | -0.42 |
| EPS Basic Continuous Ops | -0.64 | -0.61 | -0.57 | -0.65 | -0.42 |
| EPS Diluted Total Ops | -0.64 | -0.61 | -0.57 | -0.65 | -0.42 |
| EPS Diluted Continuous Ops | -0.64 | -0.61 | -0.57 | -0.65 | -0.42 |
| EBITDA(a) | $-57,126 | $-54,634 | $-51,920 | $-58,994 | $-34,886 |